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Continuous freeze-drying and its 
relevance to the pharma/biotech 
industry
Roberto Pisano
Department of Applied Science and Technology
POLITECNICO di TORINO
Freeze–drying /Lyophilization is
a process where water, or another solvent, is removed from a
frozen solution at low temperature and pressure via sublimation
Introduction
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A freeze–drying cycle encompasses three steps
Freezing
Primary drying
Secondary drying
Almost 50% of biopharmaceuticals listed by FDA and EMA is lyophi-
lized, proving that freeze-drying is the preferred way to stabilize large
molecules that are not stable in liquid, despite its high energy con-
sumptions and long processing time.
Introduction
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Freeze-drying of pharmaceuticals is performed batch-wise
Long and expensive process
Heat and mass transfer is not uniform within the batch of vials
Heterogeneity in freezing behavior
Heterogeneity in drying behavior
Poor control of product quality
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Examples of lyophilized samples 
belonging to the same lot of production
Background & Problem statement
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Past
Disconnected 
process steps
Traditional 
Batch
Manufacturing
Present
QbD & PAT
Understanding 
role and impact of 
individual steps
Near future
>2020
Blue-sky thinking
Continuous Manufacturing
Seamlessly integrated & full 
characterized process
Drawbacks of batch freeze-drying
5
Heterogeneity in freezing behavior …
temperature of nucleation is not uniform within the batch of vials,
but is stochastically distributed,
Distribution of the nucleation temperature as observed 
in a batch freeze-drying cycle
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Heterogeneity in freezing behavior …
temperature of nucleation is not uniform within the batch of vials,
but is stochastically distributed
ice structure and, hence, cake morphology changes from vial to vial0 1 2 3 4 5 6
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SEM micrographs of mannitol 5% as produced by batch freeze-drying
7Drawbacks of batch freeze-drying
Heterogeneity in freezing behavior …
temperature of nucleation is not uniform within the batch of vials,
but is stochastically distributed
ice structure and, hence, cake morphology changes from vial to vial
both primary and secondary drying behavior change from vial to vial
vial-to-vial variations in polymorphs composition
large distributions in residual moisture and potentially in API
activity/stability
Continuous freeze-drying might be beneficial to …
achieve a narrow distribution in nucleation temperature
make the frozen product morphology more uniform
make drying behavior more uniform among the vials of the batch
reduce vial-to-vial heterogeneity
8Drawbacks of batch freeze-drying
Heterogeneity in heat transfer …
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Spatial and statistical distribution of the heat transfer coefficient, between shelf 
and container, within a batch of vials. Data refer to primary drying, 10 Pa as 
chamber pressure
9Drawbacks of batch freeze-drying
Heterogeneity in heat transfer …
Evolution of pressure ratio as observed 
in a batch freeze-dryer
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Statistical distribution of the residual 
moisture within the lyophilized 
samples at the end of primary drying
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Drawbacks of batch freeze-drying
Variations in product morphology due to freezing
Variations in the residual moisture at the end of primary drying
Variations in the residual moisture at the end of secondary drying
Statistical distribution of residual
moisture within the lyophilized
samples as observed at the end of
secondary drying
The extent of heterogeneity in
freezing and drying behavior is
equipment-specific.
A cycle developed in a laboratory
freeze-dryer cannot be
transferred without modifications
to the production unit  scale up
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A new concept for the continuous freeze-
drying of unit doses
OBJECTIVE: development of a continuous freeze-dryer that produces a
final product having similar properties and structures to that obtained
by a conventional batch unit.
FILLING CONDITION-ING
VACUUM 
CHAMBER
PRIMARY 
DRYING 
MODULE
SECONDARY 
DRYING 
MODULE
BACK/STOP
PERING
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A new concept for the continuous freeze-
drying of unit doses
Filling and Loading
Conditioning module
Nucleation module
Freezing module
Primary drying module
Secondary drying module
Moving of vials
The continuous flow of vials is achieved by suspending 
the vials over a track  uniformity in heat transfer
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A new concept for the continuous freeze-
drying of unit doses
Filling and Loading
Conditioning module
Nucleation module
Freezing module
Primary drying module
Secondary drying module
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A new concept for the continuous freeze-
drying of unit doses
Filling and Loading
Conditioning module
Nucleation module
Freezing module
Primary drying module
Secondary drying module
Example of nucleation 
chambers
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A new concept for the continuous freeze-
drying of unit doses
Filling and Loading
Conditioning module
Nucleation module
Freezing module
Primary drying module
Secondary drying module
Cold air INLET
(from the 
cooling 
system)
“WARM”air OUTLET 
(to the cooling system)
The nucleated solution is 
further cooled by forced 
convection until the its 
complete solidification.
The external surface of 
the vessel is equally 
flushed by the cryogenic 
gas.
Different freezing 
protocols can be 
performed modulating 
temperature and velocity 
of cryogenic gas.
16
A new concept for the continuous freeze-
drying of unit doses
Filling and Loading
Conditioning module
Nucleation module
Freezing module
Primary drying module
Secondary drying module
Vacuum system
(condenser + vacuum pump)
Cooling/heating system
Sluice-gate/load-lock
In the primary drying module …
Vials are exposed to low 
temperature and pressure
Heat is transferred by 
radiation from 
temperature-controlled 
surfaces
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A new concept for the continuous freeze-
drying of unit doses
Filling and Loading
Conditioning module
Nucleation module
Freezing module
Primary drying
Secondary drying module
In the secondary drying module …
Vials are exposed to high 
temperature and low 
pressure so as to promote 
desorption of bounded water
Vacuum system
(condenser + vacuum pump)
Cooling/heating system
Sluice-gate/load-lock
Stoppering/sealing
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A new concept for the continuous freeze-
drying of unit doses
Flexibility & Modularity
The various modules can be combined to make the system more 
flexible and treating products from different upstream feeds.
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Experimental results
SEM images of lyophilized mannitol samples produced on constant 
drying conditions. Images refer to the same enlargement
Batch Continuous
Product morphology
More precise control of freezing conditions
Larger pores and hence smaller resistance to mass transfer 
during primary drying
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Experimental results
Product morphology
More precise control of freezing conditions
Larger pores and hence smaller resistance to mass transfer 
during primary drying
Intra-vial heterogeneity is less evident
Batch 
Continuous
top
center
bottom
SEM images of lyophilized mannitol samples
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Experimental results
Process performances
Larger pores and hence shorter primary drying
Breaks of a typical batch production can be 20% to 50% of the 
total cycle time
The overall cycle time is up to 5 times shorter
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Batch
✓
5 h
✓
2-3 h
✓
6 h
✓
LONG
✓
6 h
✓
SHORT
✓
1 h
✓
6 h
✓
6 h
Continuous
✓
< 1 h
✓
SHORTER
✓
SHORT
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Experimental results
Process performances
Larger pores and hence shorter primary drying
Breaks of a typical batch production can be 20% to 50% of the 
total cycle time
The overall cycle time is up to 5 times shorter
Distribution of the residual moisture at the end of drying is more 
uniform
Distribution of the final residual moisture for a sucrose-based 
formulation (250 vials)
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Batch Continuous
Equipment size
Case study #1 – 100,000 vials/week
The equipment volume is approx. 15 times smaller
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Experimental results
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Conclusions
Reduce the risk of product contamination
No manual handling, increased safety 
The processing time is shorter
Modular and smaller equipment and facilities
More flexible operation
Reduced inventory
Lower capital costs, less work-in-progress materials
Eliminate scale-up from lab to production units
Process flexibility
Bulk vs. particle-based material
Yield can be adjusted on market request
Improve product quality
Uniformity of the lot of production
In-line control of product quality
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Thanks for
your attention!
